Transparency Market Research
(TMR) has published a new report titled, “Orthobiologics Market - Global
Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
According to the report, the global orthobiologics market was valued at
US$ 4.8 Bn in 2017 and is projected expand at a CAGR of 5.5% from 2018 to 2026.
High prevalence of sports injuries and arthritis and rise in prevalence of
trauma injuries are anticipated to augment the global market between 2018 and
2026.
Orthobiologics comprise tissue
and bone replacement materials used to expedite healing and recovery of
ligaments, tendons, muscles, and bones. Orthobiologics are integral part of
orthopedic surgical procedures, as these assist in rapid recovery of joints,
bones, and muscles post-surgical procedure and reduce healing time.
Orthobiologics comprise products such as synthetic bone substitutes, bone
cement, allografts, stem cells, and others. Rise in the global geriatric
population increases the prevalence of chronic orthopedic diseases such as
arthritis and osteoporosis. Moreover, increase in cases of sports injury and
trauma is likely to propel the global orthobiologics market. However,
orthobiologics is a new technology and in a nascent stage of adoption.
Request a PDF Sample
- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1747
Limited reimbursement support for
orthobiologics such as stem cells and allografts is anticipated to restrain the
global market. High cost of bone grafts creates difficulty in obtaining
reimbursement. Additionally, extensive clinical studies for safety of bone
healing products is a constraint for obtaining reimbursement for
orthobiologics. Moreover, procedure developed from existing treatment, coding
options, and lack of data to differentiate the products are the various
reimbursement challenges. This hampers the growth of the global orthobiologics
market.
The report offers detailed
segmentation of the global orthobiologics market based on product, application,
and end-user. The market has also been segmented based on region (North
America, Europe, Asia Pacific, Latin America, and Middle East & Africa).
Introduction of new orthobiologics which reduce the healing & recovery time
and offer better biocompatibility with low or null adverse effects is likely to
drive the global orthobiologics market. Orthobiologics are relatively new,
hence reimbursement is less compared to other options.
Request for Analysis
of COVID19 Impact on Orthobiologics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1747
Allografts Segment to Account for Leading Share and Witness Strong
Growth
In terms of product, the
viscosupplements segment accounted for leading share of the global market in
2017 and the trend is anticipated to continue during the forecast period.
Moreover, increase in the number of regulatory approvals for allograft
orthobiologics products is projected to contribute to the growth of the segment
during the forecast period. High biocompatibility of allografts and better
efficacy are expected to drive the uptake of these products from 2018 to 2026.
The stem cell therapy segment is likely to expand at the second fastest CAGR
during the forecast period. The segment is anticipated to gain market share
from 2018 to 2026. Surge in the number of trauma cases is likely to boost the
growth of the segment.
Emerging Technologies in Orthobiologics to Propel Market
Emerging technologies in
orthobiologics is projected to boost the growth of the global orthobiologics
market during the forecast period. 3D printed implant technology helps reduce
surgery time, provides better stability, and improves clinical outcome for
orthopedic surgical procedures. SpineVision’s 3D laser printed HEXANIUM TLIF
for spine surgery helps reduce risk of subsidence in disc height in the
post-operative period. Tornier’s BioFiber Surgical Mesh is used in the
treatment of rotator cuff and other tendon injuries. SeaSpine’s OsteoBallast is
a resorbable mesh used in the treatment of spinal fusion. It helps to prevent
graft migration and simplifies graft placement.
Purchase
Orthobiologics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1747<ype=S
North America to be Most Lucrative Orthobiologics Market
North America has a large number
of orthobiologics products approved for treatment of various orthopedic
conditions. High adoption of advanced therapies in the treatment of orthopedic
conditions and favorable reimbursement policies for orthobiologics contributed
to North America’s leading market share. Large geriatric population, increase
in incidence of trauma and injuries, and demand for quality health care are
likely to contribute to the region’s leading share during the forecast period.
Product Launches by Key Players and Patent Approvals to Boost Market
The report also provides profiles
of leading players operating in the global orthobiologics market. These include
Medtronic, DePuy Synthes (Johnson & Johnson), Sanofi, Seikagaku
Corporation, Stryker, MTF Biologics, Bioventus, Artthrex, Zimmer Biomet, RTI
Surgical, Inc., Alphatec Spine, Inc., Exactech, Inc., Globus Medical, Inc., and
Integra LifeSciences. Launch of new products and focus on developing
technologically advanced products by companies, and patent approvals are
expected to drive the global market during the forecast period. In September
2018, NuVasive, Inc. launched a new product line for Propel DBM.
To broaden the product line, the
company provided Propel DBM gel and Propel DBM Putty with osteoconductive
property which help to promote bone growth. In March 2018, Synergy Biomedical
LLC received clearance from Therapeutic Goods Clearance (TGA) in Australia for
BioSphere Putty, a synthetic bone graft product that helps bone healing.
More Trending Reports by Transparency Market Research –
PAP and Paracetamol
Market: https://www.biospace.com/article/global-pap-and-paracetamol-market-is-driven-by-rise-in-need-for-pain-management/
Read our Case study
at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
